Skip to content
★ Sign in to follow
NN

Nicholas N. Vahanian

CEO
Lumos Pharma, Inc.
Total declarations
63
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (31 ops.)
€10.4M

Latest filing published 04 Jan 2019 for Lumos Pharma, INC., €3,228.

Insider track record

Disclosed buys
0
Disclosed sells
31
Signal history

Nicholas N. Vahanian: trading record in brief

Nicholas N. Vahanian is a declared insider of Lumos Pharma, Inc., with filings sourced from SEC (Form 4). We count 63 filings; the first trade dates from 16 November 2011 and the latest from 4 January 2019.

The open-market record consists of 31 sales worth €10.4M, with no purchase. Besides market trades, the filings include 16 share grants and 14 option exercises.

Most recently, on 4 January 2019, the filings show a share grant worth €3,573 in Lumos Pharma, Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Nicholas N. Vahanian

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations61 total

25 of 61 declarations